Supplementation of Zinc and the Amino Acid Cysteine towards the TNF-? Status, Calcium, and Anthropometry to the Stunting Infants after Being Given High Doses of Vitamin A by Hendrayati, Hendrayati et al.
 International Journal of Sciences: 
Basic and Applied Research 
(IJSBAR) 
 
ISSN 2307-4531 
(Print & Online) 
 
http://gssrr.org/index.php?journal=JournalOfBasicAndApplied 
-------------------------------------------------------------------------------------------------------------------- 
Supplementation of Zinc and the Amino Acid Cysteine 
towards the TNF-α Status, Calcium, and Anthropometry 
to the Stunting Infants after Being Given High Doses of 
Vitamin A 
Hendrayati a*, Suriani Rauf b, Aswita Amir c 
aNutrition Department of Health Polytechnic in Health Ministry of Makassar Indonesia; Doctoral Program in 
Health Sciences, Airlangga University Surabaya,  Indonesia 
b,cNutrition Department of Health Polytechnic in Health Ministry of Makassar Indonesia 
 
 
 
Abstract 
The growth of stunting infants can also be monitored through the anthropometric status, like theweight and the 
height. There are other indicators that can be used as the indicators of the growth of infant stunting; a biomarker 
of the bone growth, such as TNF-α and calcium. At the time of the matrix maturation, the bone cells of 
osteoblast forms the calcium ions as inorganic minerals that can increase the bone mass and speed up the 
addition height of the children. TNF-α is a pro inflammatory mediator, which is indispensable during the bone 
growth. Giving high doses of vitamin A has not effectively address the problem of the stunting infants so that 
the additions of other supplements are required, namely zinc and the amino acid cysteine. Cysteine amino acid 
speed up the hormone receptor transcription in the reaction of zinc finger protein (ZFP), induction of 
Transforming Growth Factor β (TGF β), and the formation of Cysteine Rich Intestinal Protein (CRIP) that are 
strongly associated with the presence of zinc.  
------------------------------------------------------------------------ 
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Supplementation of zinc and the amino acid cysteine was conducted over three (3) consecutive months to 
thestunting infants, who have obtained the high doses of vitamin A. Determination of TNF α levels and calcium 
were performed in pre and post using Eliza Human TNF α Kit and Eliza Human Calcium Kit. Anthropometry, 
which include weight and height measured every month. Result show that the provision of zinc and the amino 
acid cysteine to the stunting infants who have acquired high doses of vitamin A can affect the levels of TNF-α 
and calcium; and can improve the anthropometric status, which includes weight and height. Giving zinc and the 
amino acid cysteine is an alternative companion to the highdoses of vitamin A to help repairing the bone growth 
disorders to the infants stunting. 
Keywords: Stunting, Zinc; Cysteine Amino Acids; Vitamin A; TNF-α; Calcium; Weight, Height. 
1. Introduction  
Stunting or short stature is a nutritional problem gaining well attention both nationally and internationally. The 
problem of short stature to the infants related to the impaired linear growth. One of the causes of the short infant 
nutritional problem is the disturbance of the bone growth. In supporting the bone growth, highdoses of vitamin 
A needs other micronutrients [1]. Zinc is one of themicro minerals that have a role in the protein synthesis and 
the function of the cellular enzymes so that the role of zinc in the bone growth is enormous. Currently, 
approximately 20% of the infants’ population in the world haverisk of zinc deficiency from the daily food. 
UNICEP, USAID and WHO concluded that zinc supplementation isvery needed in some countries, including 
Indonesia [2]. 
Zinc, in addition to a role in the synthesis of Retinol Binding Protein (RBP), it also plays an important role in 
the bone cell differentiation process to achieve the optimal linear growth to the children in infancy. In the 
process of differentiation, the bone cells require zinc amino acid cysteine and histidine. Both of these amino 
acids are known to work in gene regulation. Klug mentioned it as zinc-finger. Zinc-finger shapes require four 
amino acid residues as ligands, namely two cysteineand two histidine in each zinc molecule [3]. The second 
bonding pattern of amino acids and zinc are called Zinc-Finger Protein (PZF). PZF is important for the binding 
of the transcription factors to DNA by binding histidine and cysteine residues in the transcription factors and 
nuclear hormone receptors. Zinc puts finger-like secondary structure on the protein. This structure can increase 
the transcription factor on the gene promoter [4]. 
Another mechanism that can be done by zinc in the bone growth through positive effects on the stimulant 
hormonal stimulation is the hormone that is necessary for the differentiation, proliferation, and maturation of 
lymphocytes T. 
Lymphocytes T has a role as cells that can induce TNFα, IFNγ, IL-1, IL-6, and IL-11 that play a role in the 
regulation of the Growth Hormone (GH) to induce Insulin Like Growth Factor 1 (IGF-1). IGF-1 requiresthe 
Insulin Receptor Substrate 1 (IRS1) on the proliferation of the bone cells or osteoblasts [5]. Basically, the 
stunting infant growth may also be seen from the growth of the anthropometry, in this case the weight and 
height, which in fact at the time of the maturation matrix, the bone osteoblasts form the calcium ions as 
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inorganic minerals, which can increase the bone mass and speed up the addition of the children’s height [6]. 
Cysteine amino acid accelerate the hormone receptor transcription on the reaction of Zinc Finger Protein (ZFP), 
induction of Transforming Growth Factor β (TGF β), and the formation of Cysteine Rich Intestinal Protein 
(Crip) that were strongly associated with the presence of zinc [4]. This research study is to assess the linear 
growth to the stunting infants through the changes in the levels of TNF-α, Calcium, and anthropometry through 
the provision of zinc and the amino acid cysteine after being given supplementation of highdoses of vitamin A 
to the infants stunting. 
2. Materials and Methods  
This research is an experimental research with randomized pretest posttest control group design. Treatment 
approach uses double blind methods. The sample in this research werethe infants who pass in the screening with 
short stature criteria based on the index of the body height/age at -2SD to -3SD, not in ill circumstance. The 
samples were taken randomly. The research sample were in the two (2) groups, the group given Zinc + cysteine 
amino acid  + highdoses of Vitamin A, and the group given high doses of Vitamin A. 
Dosage of the supplements given by Zinc is in the form of zinc sulfate syrup. Giving 5 ml of zinc syrup with 
zinc sulfate content of 27,45 mg is equivalent to 10 mg of zinc. Zinc supplementation is done every day for 
three consecutive months. Cysteine amino acid is in the powder form, insipidity, and white as flour. The 
administered dose is 25 mg/day at the time of the administration for three consecutive months. Supplementation 
of high doses of vitamin A (200.000 SI) follows the government program conducted simultaneously in August 
2015. 
Data collected include primary and secondary data. Primary data was obtained from the measurement result of 
TNF α levels using Human Kit TNF αEliza, calcium levels using Human Kit Calcium Eliza, and anthropometry 
includes weight and height. Statistical analysis is used to test the hypothesis using a paired test to test the 
differences in increased levels of TNF-α, calcium, and anthropometric before and after the treatment in each 
group. 
3. Results  
The total number of the samples in this research were as many as 30 samples divided into group 1 (one); the 
treatment in giving Zinc + Cysteine Amino Acids + High Doses of Vitamin A, and group 2 (two) as a control; 
the infants who have gained a high dosesof vitamin A. The time in doing the research was conducted in August 
2015, following the schedule of the government in terms of giving the supplementation of highdoses of vitamin 
A to the infants simultaneously held throughout Indonesia. 
Table 1 shows the nutritional status based on the height/age with a very short category reached 53,34% and 
short as amounted to 46,66%. If it is seen from the indicators of weight/age of the samples in this research, the 
samples have good nutritional status as many as 93,34% in the first group and 73,33% of in the second group. 
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Table  1: The Characteristic Sample of the Stunting Infants 
Characteristic Sample Group 1 Group 2 
n % n % 
Age (month) 
≤ 30 
>31 
 
6 
9 
 
40 
60 
 
4 
11 
 
26.67 
73.33 
Total 15 100.00 15 100.00 
Sex 
Male 
Female 
 
6 
9 
 
40 
60 
 
5 
10 
 
33.34 
66.66 
Total 15 100.00 15 100.00 
Nutritional Status 
Height/Age 
Short 
Very Short 
Total 
Weight/Age 
Good Nutrition 
Malnutrition 
 
 
7 
8 
15 
 
14 
1 
 
 
46.66 
53.34 
100.00 
 
93.34 
  6.66 
 
 
7 
8 
15 
 
11 
4 
 
 
46.66 
53.34 
100.00 
 
73.33 
26.67 
Total 15 100 15 100 
Table 2: Differences of TNF α Level between Before and After the Treatment to the Stunting Infants Sample 
Group 1 Mean Standar Deviasi P value 
Before 23,320 2,1078 0,008 
After 26,066 4,2525 
Group 2    
Before 22,286 1,9522 0,259 
After 23,253 2,1563 
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Table 2 illustrates that the average level of TNF-α before giving zinc + Cysteine & + Vitamin A (group 1) is 
23.320 pg/ml with a variation of 2.1078 pg/ml. After the administration, there is an increase of 2.746 pg/ml to 
an average of 26.066 pg/ml with a variation of 4.252 pg/ml. Results of the statistical test       (t test) generate P 
value=0,008. It means that there are significant differences in the levels of TNF α between before and after the 
administration of zinc + cysteine + vitamin A. 
Table 3: Differences of Calcium Levels between Before and After the Treatment to the Stunting Infants Sample 
Group 1 Mean Standar Deviasi P value 
Before   8,5533 1,5468 0,0001 
After 17,4067 3,4658 
Group 2    
Before 14,0800 5,9538 0383 
After 16,6133 7,1607 
 
Calcium levels of the measurement results is shown in Table 3, which suggests that the average calcium levels 
before giving zinc + Cysteine & + Vitamin A (group 1) is 8,5533 mg/ml with a variation of 1,5468 mg/ml. After 
the administration happens, there is an increase of 8,8534 mg/ml to an average of 17,4067 mg/ml with a 
variation of 3,4658 mg/ml. Based on the results of the statistical tests (t test), P value=0,0001 is obtained. This 
means that there are significant differences in the calcium levels between before and after giving zinc + Cysteine 
+ Vitamin A. 
Table 4: Differences of Weight between Before and After the Treatment to the Stunting Infants Sample 
Group 1 Mean Standar Deviasi P value 
Before 12,81 1,71 0,0001 
After 14,70 1,44 
Group 2    
Before 11,95 1,39 0,0001 
After 12,71 1,37 
 
In table 4, it appears that there is an increase of 1,89 Kg weight in group 1, and 0,76 kg in group 2. Statistical 
test results showed the P value = 0.0001. This means there is a significant change in Weight both group 1 and 
group 2. 
Height measurement results can be explained in Table 5.Compared to weight, the conclusion can be drawn that 
the weight and height equally increased. 
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Table 5: Differences of Height between Before and After the Treatment to the Stunting Infants Sample 
Group 1 Mean Standar Deviasi P value 
Before 85,06 3,57 0,0001 
After 86,67 3,50 
Group 2    
Before 83,18 3,53 0,0001 
After 84,71 3,43 
 
In Table 5, it appears that there is an increase of 1.61 cm height in group 1, and 1.53 cm in group 2. Statistical 
test results show the P value =0.0001. It means that there is a significant change in height either in group 1 or in 
group 2. 
4. Discussion  
Bone growth disorders can cause the disruption of the linear growth, so it causes the children under five to 
suffer the short nutritional status [7]. One treatment done to address this problem is by giving the 
supplementation of the highdoses of Vitamin A. Vitamin A effectsto the protein synthesis in the cell growth, 
including the bone cells [7, 8]. 
This research provides the additional zinc and the amino acid cysteine in the supplementation of Vitamin A, 
which is already implemented as a program of the Indonesian government. Zinc is potential as an immune 
stimulant on the immune-cellular response. The effect of zinc on the immune system, among others, is an 
inhibitor of apoptosis that is very necessary when the bone growth through the suppression of the glucocorticoid 
hormone secretion, which is an apoptosis inducer for the timosit and precursor T cells [9]. Mature T 
Lymphocytes induces the receptors of the expression of TNFα, IFNγ, IL-1, IL-6, and IL-11. These cytokines are 
involved in the process of the bone remodeling  [7, 10]. 
Results of the analysis of TNF α level in this research show the P value of 0,008 in the sample given zinc + 
cysteine + Vitamin A. This shows that there is an impact from the treatment of TNF α level to the stunting 
infants. The main goal of treatment procedure of this research is to look at the status of the bone repair. The 
connection of TNF-α in repairing the bone growth plays a role in stimulating the osteoclasts to stimulate the 
production of RANKL by the stromal cells, and also induces the secretion of RANKL by T lymphocytes, B 
lymphocytes, and endothelial cells to induce the osteoclast formation indirectly. TNF-α also stimulates the 
production of M-CSF by the stromal cells. Osteoclast differentiation factor (ODF, also called 
RANKL/TRANCE/OPGL) stimulates the osteoclast progenitors on the monocytes/macrophages into the 
osteoclasts in the presence of the macrophage colony-stimulating factor (M-CSF) [11]. 
The process of bone remodeling is a process that generates the growth and the bone turnover. Remodeling 
process sequence is a sequence that is certain, namely activation resorption and formation (ARF). The phase 
32 
 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2016) Volume 25, No  2, pp 27-35 
 
between the ARF has a between phase, which is reversal phase involving some mononuclear cells such as 
macrophages that form the cemen line to limit the process of the resorption and glue the old and the new bones 
[12]. 
Another local factorsthat play a role in the remodeling process are IGF, TGF, Fibroblast-Growth Factor (TGF), 
Platelet Derived Growth Factor (PDGF), Interleukin (IL), Tumor Necrosis Factor α (TNF α) Colony Stimulating 
Factor (CSF), and interferon (IFN) [3. 13]. 
The role of cytokines in the early remodeling is very important. Cytokines are the protein mediator and the 
mediator in the physiological pathology response to the infection. TNF α, besides playing a role in the 
inflammatory process in the bone remodeling, is also a growth factor because there are in almost all 
changedcells, including osteoblasts [9]. TNF α, also called as cachectic, is an immune cytokine produced by the 
macrophages. TNF-α can induce the expression of an autocrine growth factor, increase the cellular response to 
the growth factors, and induce the signaling pathways that lead to the proliferation. TNF-α acts synergistically 
with EGF and PDGF on some cell types, including the bone cells [11]. 
TNF-α may increase the osteoclast genesis through two different mechanisms, namely TNF-α first affects the 
osteoclast genesis at the osteoclasts precursors in the bone marrow by the basic cells to the air differentiation 
into c-Fms+/CD11b+/RANK+/- of the osteoclasts progenitors through the independent mechanisms of 
RANKL/RANK. Osteoclast precursors are entered into the blood vessels and peripheral tissues, and thenthey 
differentiate into the mature osteoclasts (dependent mechanism) whose role is to speed up the process of the 
bone resorption. Another indicators of the bone repair analyzed in this research are the levels of the calcium. 
The results show the P value=0,0001. It indicates that this research improves the treatment of the plasma 
calcium status, where nearly 50% of the calcium is calcium ionized plasma with the reference to 1,0-1,2 mmol/l. 
The rests are not bound ionized to the citrate. The other 50% of plasma calcium is bound to the proteins, 
primarily albumin. Physiologically, the calcium is active free and responsible to the bone growth and the 
neuromuscular effects [4,7,14]. 
Zinc interacts with the hormones involved in the bone growth, such as somatomedin C, osteocalsin, testosterone, 
thyroid hormone, and insulin. Therefore, zinc is closely associated with the bone metabolism. Zinc acts 
positively to the growth, including the bone growth [15]. Long bone growth disorders, in addition to the 
elements influenced by the nutrients, are also affected by the disruption of the hormone regulation during the 
formation of the long bones. One hormone disturbed is IGF-1. IGF-1 plays an important role as an introduction 
to the signal when the elongation of the bone cells happens. The existence of IGF-1 is influenced by the levels 
of zinc. Proven zinc supplementation can correct the linear growth [5]. 
This research results a real change in the anthropometric, ieweight and height in both groups. This shows that 
zinc, amino acids cysteine, and vitamin A are as good as for the anthropometric status. Zinc can change the 
appetite controls by the direct way on the central nerve system and change the levels of the receptor 
responsiveness to the neurotransmitter. Zinc deficiency is usually followed by the changes in ability and acuity 
of taste and smell through the disruption of the appetite, and eventually can lead to low nutrient intake and 
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weight loss as well as the disruption of the linear growth [8,11].  
The role of the amino acid cysteine in the process of transcription is one of the cell differentiation processes, 
where the process is initiated by the binding of the promoter and transcription cofactor that cause the 
transcription of DNA. For instance, morphogenetic bone protein causes mRNA transcription involved in 
osteogenesis [16,17]. By nature, cysteine has a special role in the structure of the protein, such as insulin, IGF, 
growth factors, immunoglobulin, or antibodies [18]. The area of cysteine between the fifth and the sixth is 
displayed on the surface of the molecule and receptor binding as seen in the beginning of the transcription of the 
cell. Cysteine knot is a monomer form of the growth factor [17, 19]. 
5. Conclusion 
Giving zinc and the amino acid cysteine to the stunting infants who have acquired high doses of Vitamin A can 
affect the levels of TNF-α and calcium levels; and can improve the anthropometric status, which includes 
weight and height. 
Giving zinc and the amino acid cysteine is acompanionalternative to the highdoses ofVitamin A to help 
repairing the bone growth disorders to the stunting infants. 
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